Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3,980.00p
   
  • Change Today:
      30.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 3,800.00
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 1,182
  • Market Cap: £207.33m

Dividend Data

  30-Jun-2030-Jun-1930-Jun-1830-Jun-1730-Jun-16
Total Dividend88.00p73.00p61.00p51.00p42.50p
For more dividend details, click here

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 30-Jun-20 30-Jun-19 30-Jun-18 30-Jun-17 *30-Jun-16
Continuing Operations          
Revenue 10.31 9.29 7.98 7.25 a5.52
Operating Profit/(Loss) 8.18 6.93 6.83 5.72 a4.21
Net Interest 0.04 0.03 0.03 0.06 a0.01
Profit Before Tax 8.23 6.97 6.87 5.77 a4.22
Profit After Tax 7.20 5.86 5.66 4.92 a3.49
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD 7.20 5.86 5.66 4.92 3.49
Attributable to:          
Equity Holders of Parent Company 7.20 5.86 5.66 4.92 n/a
Minority Interests n/a n/a n/a n/a n/a
           
Continuing EPS          
Earnings per Share - Basic 139.41p 114.04p 110.21p 96.36p n/a
Earnings per Share - Diluted 137.93p 112.12p 108.31p 94.70p n/a
Earnings per Share - Adjusted 139.41p 114.04p 110.21p 96.36p n/a
Continuing and Discontinued EPS          
Earnings per Share - Basic 139.41p 114.04p 110.21p 96.36p 69.18p
Earnings per Share - Diluted 137.93p 112.12p 108.31p 94.70p 67.95p
Earnings per Share - Adjusted 139.41p 114.04p 110.21p 96.36p 69.18p
           
Dividend per Share 88.00p 73.00p 61.00p 51.00p 42.50p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 30-Jun-20 30-Jun-19 30-Jun-18 30-Jun-17 *30-Jun-16
Assets          
Non-Current Assets          
Property, Plant & Equipment 0.72 0.51 0.50 0.45 0.47
Intangible Assets n/a n/a n/a n/a n/a
Investment Properties n/a n/a n/a n/a n/a
Investments 0.61 0.39 0.29 0.20 0.04
Other Financial Assets n/a n/a n/a n/a n/a
Other Non-Current Assets n/a n/a n/a n/a n/a
  1.33 0.90 0.79 0.64 d0.51
Current Assets          
Inventories 0.25 0.24 0.28 0.23 0.20
Trade & Other Receivables 3.65 3.93 3.82 3.34 2.69
Cash at Bank & in Hand 8.08 6.54 6.99 6.17 5.38
Current Asset Investments n/a n/a n/a n/a n/a
Other Current Assets n/a n/a n/a n/a n/a
  11.97 10.71 11.09 9.74 b8.27
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 13.30 11.61 11.88 10.38 8.78
           
Liabilities          
Current Liabilities          
Borrowings 0.73 0.76 0.84 0.22 n/a
Other Current Liabilities n/a n/a n/a n/a 0.55
  0.73 0.76 0.84 0.22 0.55
           
Net Current Assets cn/a cn/a cn/a cn/a 7.71
           
Non-Current Liabilities          
Borrowings n/a n/a n/a n/a n/a
Provisions 0.05 0.03 0.03 0.02 0.02
Other Non-Current Liabilities n/a n/a n/a n/a en/a
  0.05 0.03 0.03 0.02 0.02
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 0.78 0.79 0.86 0.24 0.57
           
Net Assets 12.52 10.83 11.01 10.14 8.21
           
Capital & Reserves          
Share Capital 0.26 0.26 0.26 0.26 0.25
Share Premium Account 1.31 0.44 0.40 0.40 0.08
Other Reserves n/a n/a n/a n/a n/a
Retained Earnings 10.95 10.13 10.36 9.49 7.88
Shareholders Funds 12.52 10.83 11.01 10.14 8.21
           
Minority Interests/Other Equity n/a n/a n/a n/a n/a
Total Equity 12.52 10.83 11.01 10.14 8.21
Cash Flow 30-Jun-20 30-Jun-19 30-Jun-18 30-Jun-17 *30-Jun-16
Net Cash Flow From Operating Activities 7.68 5.88 5.92 3.96 h3.17
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a n/a
Taxation Paid fn/a fn/a fn/a fn/a n/a
Net Cash Flow from Investing Activities (0.52) (0.15) (0.17) (0.12) in/a
Acquisitions & Disposals gn/a gn/a gn/a gn/a n/a
Dividends Paid fn/a fn/a fn/a fn/a (1.92)
Management of Liquid Resources cn/a cn/a cn/a cn/a n/a
Net Cash Flow from Financing Activities (5.62) (6.18) (4.93) (3.05) n/a
Net Increase/Decrease In Cash 1.54 (0.45) 0.82 0.79 1.25
Ratios - based on IFRS 30-Jun-20 30-Jun-19 30-Jun-18 30-Jun-17 *30-Jun-16
Continuing Operations          
PE Ratio - Adjusted 29.8 32.8 26.7 19.8 n/a
PEG - Adjusted 1.4 8.2 1.9 n/a n/a
Earnings per Share Growth - Adjusted 22% 4% 14% n/a n/a
Dividend Cover 1.58 1.56 1.81 1.89 n/a
Revenue per Share 197.91p 178.33p 153.19p 139.17p a105.96p
Pre-Tax Profit per Share 157.99p 133.80p 131.88p 110.76p a81.01p
Operating Margin 79.34% 74.60% 85.59% 78.90% a76.27%
Return on Capital Employed n/a n/a n/a n/a an/a
Continuing & Discontinued Operations          
PE Ratio - Adjusted 29.8 32.8 26.7 19.8 13.9
PEG - Adjusted 1.4 8.2 1.9 0.5 0.4
Earnings per Share Growth - Adjusted 22% 4% 14% 39% 37%
Dividend Cover 1.58 1.56 1.81 1.89 1.63
           
Dividend Yield 2.1% 2.0% 2.1% 2.7% 4.4%
Dividend per Share Growth 20.55% 19.67% 19.61% 20.00% 30.37%
Operating Cash Flow per Share 147.48p 112.83p 113.68p 75.96p j60.85p
Cash Incr/Decr per Share 29.55p (8.62p) 15.73p 15.10p 24.00p
Net Asset Value per Share (exc. Intangibles) 240.36p 207.82p 211.37p 194.74p 157.60p
Net Gearing -58.68% -53.40% -55.87% -58.62% n/a

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.

 

Top of Page